Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia
Pavia, Lombardy, 27100, Italy
NCT Number: NCT06864949
The present study aimed to investigate the cross-sectional effect of Class I AMCOP devices in patients of all possible skeletal types from both vertical skeletal pattern (normodivergent, hyperdivergent, hypodivergent) and sagittal skeletal pattern (skeletal Class I, skeletal Class II, skeletal Class III).
The criterion for choosing patients was determined by the protocol of using these devices, which is to always perform an AMCOP First Class phase with the aim of improving transverse coordination of the arches, Spee's Curve and Wilson's Curve.
Interested in participating?
Request Info7 year–13 year
All sexes
Interventional
Not applicable
Pavia, Lombardy, 27100, Italy
This prospective clinical study will investigate the cross-sectional effect of Class I AMCOP (Cranium Occluded Postural Multifunctional Harmonizers, Micerium spa) devices in patients of all possible skeletal types from both vertical skeletal pattern (normodivergent, hyperdivergent, hypodivergent) and sagittal skeletal pattern (skeletal Class I, skeletal Class II, skeletal Class III).
Patients willing to start AMCOP therapy and recruited for the study will be asked to sign the informed consent. Parents will sign the consent for underage patients.
We will recruit patients by following specific inclusion and exclusion criteria during an orthodontic examination.
Diagnostic records will be recorded before treatment (T0) and after 10-12 months of treatment (T1) and included:
Changes will be evaluated at T0 and T1 as follows:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The device measure will be determined with OrthoCad program on digital models, taking the distance between the vestibular cusps of the upper first molars, at the level of the most prominent point. AMCOPs are preformed devices and there are five different measures based on transverse diameter: 1 (45mm), 2 (50mm), 3 (55mm), 4 (60mm), 5 (65mm).
Requiring expansion, we will choose an higher AMCOP measure than the transverse distance measured on the digital models at T0.
The clinical indications for use of the AMCOP device will be as follow:
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
The upper intermolar distance take as reference the top of the mesiovestibular cusp of the upper first molars.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
The upper intercanine distance take as reference the top of upper canine cusp.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
The lower intercanine distance take as reference the top of lower canine cusp.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
ANB angle will be calculated using the pre-treatment and the post-treatment lateral cephalometric radiographs.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
Wits Index will be calculated using the pre-treatment and the post-treatment lateral cephalometric radiographs.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
Skeletal Class will be assessed combining the ANB angle and Wits Index values using the pre-treatment and the post-treatment lateral cephalometric radiographs.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
Cranio-Mandibular Angle will be evaluated between SN and GoGn planes following Giannì analysis and using the pre-treatment and the post-treatment lateral cephalometric radiographs.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
Intermaxillary Angle will be evaluated between bispinal and mandibular planes following Giannì analysis and using the pre-treatment and the post-treatment lateral cephalometric radiographs.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
Skeletal vertical pattern will be assessed using Cranio-Mandibular and Intermaxillary Angles following Giannì analysis and using the pre-treatment and the post-treatment lateral cephalometric radiographs.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
Articular Angle will be evaluated between SArGo points following Giannì analysis and using the pre-treatment and the post-treatment lateral cephalometric radiographs.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
Upper and Lower goniac angles will be evaluated between respectively Ar-Go-N and N-Go-Gn points following Giannì analysis and using the pre-treatment and the post-treatment lateral cephalometric radiographs.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
Mandibular growth pattern will be assessed using Articular Angle and Upper and Lower Goniac Angles, following Giannì analysis and using the pre-treatment and the post-treatment lateral cephalometric radiographs.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
Upper incisors Inclination will be evaluated between upper incisors Axis and bispinal plane, following Giannì analysis and using the pre-treatment and the post-treatment lateral cephalometric radiographs.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
Upper incisors Inclination will be evaluated between lower incisors Axis and mandibular plane, following Giannì analysis and using the pre-treatment and the post-treatment lateral cephalometric radiographs.
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
Dento-alveolar discrepancy will be calculated using the pre-treatment and the post-treatment study models using "Tanaka and Jhonston" space Analysis
Time frame: Before treatment (T0) and after 10-12 months of treatment (T1)
The lower intermolar distance take as reference the top of the mesiovestibular cusp of the lower first molars.
University of Pavia
Other
Efficacy of Transverse Maxillary Expansion With AMCOP Preformed Appliances: Prospective Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07695584
Oxidative Stress, Transverse Maxillary Deficiency
Izmir, Turkey (Türkiye)
View Trial DetailsNCT07086612
Apnea, Dyssomnias
Rouen, France
View Trial DetailsNCT07500194
Maxillary Expansion, Posterior Crossbite
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT07485478
Skeletal Class III Malocclusion, Transverse Maxillary Deficiency
Bangkok, Thailand
View Trial Details